Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Bio-3D printing of scaffold-free ADSC-derived cartilage constructs comparable to natural cartilage in vitro.

Nonaka T., Murata D., Yoshizato H., Kashimoto S., Nakamura A., Morimoto T.

Animal Study with a reported sample of 12 on Osteoarthritis, Cartilage Damage, published in J Orthop Surg Res (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
J Orthop Surg Res (2025)
Country
England
Reported sample size
12
Source database
PubMed
PMID
39979971
PMCID
PMC11844123
DOI
10.1186/s13018-025-05604-7
Citations
10

Abstract (original English)

Background In end-stage osteoarthritis (OA), osteochondral defects reach the subchondral bone and cartilage tissue of sufficient thickness is required to compensate for the defects. Adipose-derived mesenchymal stem/stromal cells (ADSCs), which are abundant in the body, have the potential to differentiate into cartilage and may be a useful cell source for cartilage regeneration. If it is possible to fabricate ADSC-derived cartilage constructs that can cover the damaged area, this could lead to the development of a new regenerative therapy for OA that could replace the currently available treatments. We therefore sought to produce cartilage constructs with suitable thickness and biological properties, similar to native cartilage, using the bio-three-dimensional (3D) printer. We also investigated the culture protocol to ensure that the constructs were fully mature even at the internal site. Methods ADSCs were isolated from three rats and expanded to create cartilage spheroids. The spheroids were arranged into patches using a Kenzan bio-3D printer to create scaffold-free, cell-only cartilage constructs. Basic fibroblast growth factor (bFGF) was added during expansion culture and varying concentrations of bone morphogenetic protein2 (BMP2) were supplemented during chondrogenic differentiation. The levels of glycosaminoglycans (GAG) in the spheroids and constructs were measured. The

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Printing, Three-DimensionalAnimalsMesenchymal Stem CellsRatsTissue EngineeringTissue ScaffoldsCartilage, ArticularChondrogenesisCells, CulturedAdipose Tissue

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research